CRISPR-Cas9 targeted knockout of the ERVW-1 locus was successful in HH514-16 BL cells, but a stable knockout line was unable to proliferate and establish, likely due to a required role for Syncytin-1 in B cell proliferation. This evidence concerns the gene ERVW-1 and Burkitt lymphoma.